Bondis Oppro C1 Deactivator Analysis Kit - Taiwan Registration 52e5e87c50ee975d53893be204eecdca
Access comprehensive regulatory information for Bondis Oppro C1 Deactivator Analysis Kit in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 52e5e87c50ee975d53893be204eecdca and manufactured by THE BINDING SITE GROUP LTD. The authorized representative in Taiwan is EVERLIGHT BIOTECH(TAIWAN) CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Product Details
This product is used with the Bondis Optilite analyzer for in vitro quantification of C1 deactivators present in serum.
C Immunology and microbiology
C.5250 ่ฃ้ซC1ๆๅถๅ(ๅปๆดปๅๅ)ๅ ็ซ่ฉฆ้ฉ็ณป็ตฑ
Input;; QMS/QSD
Dates and Status
May 18, 2021
May 18, 2026

